Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients
Academic Article
Publication Date:
2018
abstract:
Introduction: The soluble receptor of urokinase plasminogen activator (suPAR) is an innate immunity/inflammation biomarker predicting cardiovascular (CV) and non-CV events in various conditions, including type 2 diabetic patients on dialysis. However, the relationship between suPAR and clinical outcomes in the hemodialysis population at large has not been tested.
Iris type:
01.01 Articolo in rivista
Keywords:
cardiovascular mortality; hemodialysis; mortality; noncardiovascular mortality; soluble urokinase plasminogen activator receptor (suPAR)
List of contributors:
Tripepi, GIOVANNI LUIGI; Pizzini, Patrizia; Torino, Claudia
Published in: